Novel Double Agent Promising for Weight Loss in T2D
(MedPage Today) -- Trial tests efficacy and safety of a GLP-1 and glucagon receptor dual agonist
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news
More News: Primary Care | Weight Loss